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Cerebral embolic events related to carotid and cardiac disease have been known for decades. Recently, cerebral
embolic events have become a focus of clinical importance as complications of vascular procedures. Further,
the development of new technologies and procedures has increased the overall clinical significance. Although
the relative safety of these procedures is usually defined by acute stroke risk, it is also becoming clear that far
more subclinical events are occurring. Recent reports provided substantial evidence of memory loss, cognitive
decline, and dementia related to these so-called silent infarcts. Literature reports of magnetic resonance imag-
ing events lead to an estimate of as many as 600,000 patients with new brain injury each year in the United
States alone. Given the magnitude of the numbers involved, the impact of accelerated cognitive loss and prema-
ture senescence in a vulnerable at-risk population could well be significant. (J Am Coll Cardiol 2012;60:
1614–6) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.06.037Cerebral embolic events related to carotid and cardiac
disease have been known for decades and have formed a
central part of clinical stroke research and management.
More recently, cerebral embolic events have become a focus
of clinical importance as complications of vascular proce-
dures. Surgical and endovascular procedures, both neuroin-
terventional and cardiac, are associated with embolic risks,
and the development of new technologies and procedures
has increased the overall clinical significance. Although the
relative safety of these procedures is usually defined by the
acute stroke risk, it is also becoming clear that far more
subclinical events are occurring. Although the fundamental
issues of the nature of the embolic particles, precise mech-
anisms of cerebral injury, and effective prevention remain
debated and unclear, recent reports have provided substan-
tial evidence of memory loss, cognitive decline, and demen-
tia related to these so-called silent infarcts.
The Question: Are These
Events Really Asymptomatic?
In the world of stroke neurology, the early concept of
multi-infarct dementia has rapidly evolved to one of vascular
cognitive decline. It is clear that cerebral vascular disease
and cognitive decline travel hand in hand. Vascular risk
factors of hypertension, hyperlipidemia, and ischemic white
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It may well be that the age at which noticeable cognitive loss
develops depends on the aggregate accumulation of aging
neurons and focal tissue injury. In a recent study, 717
individuals 65 years of age without dementia were en-
rolled in a study involving magnetic resonance imaging
(MRI) and extensive neuropsychological testing (1). Not
surprisingly, mild cognitive impairment was found com-
monly and associated with decreased hippocampal volume,
presumably secondary to neuronal aging and atrophy. But
the most notable finding was the association of cortical or
subcortical infarctions with memory impairment. The study
counted infarcts of 3 mm, most clinically silent, and
demonstrated an independent association with global mem-
ory dysfunction. Recent reports based on neuropathological
findings demonstrated that even microinfarctions are asso-
ciated with lower cognition and memory, especially if
multiple lesions are present (2,3).
The Problem: The Potential Problem Is Large
The annual number of patients in the United States who
undergo surgical or endovascular procedures related to
cerebral, carotid, or coronary disease is sizable, and the
resulting number of patients at risk of cerebral infarcts is
significant and troubling. Looking at the most common
vascular procedures leads to an estimate of 2.5 million
patients treated annually, many with multiple procedures.
This number would be predicted to continue to grow, with
expanding indications for newer procedures such as
transaortic valve implantation and atrial fibrillation ablation.
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various procedures leads to an estimate of as many as
600,000 patients with new brain injury each year in the
United States alone (Table 1). This number is likely an
underestimate of the true phenomenon. More sensitive
imaging with high field strength, 3-T magnetic resonance
scanners demonstrated 30% more diffusion-weighted im-
aging (DWI) lesions than the conventional 1.5-T units in a
study of patients after carotid stenting and endarterectomy
(4). The occurrence of procedure-related asymptomatic
lesions likely rivals clinical stroke, estimated at 750,000
cases per year in the United States.
Routine MRI of patients before and after vascular pro-
cedures has provided insight into this issue and fueled
concern for the problem. Ischemia rapidly leads to cellular
events that restrict free movement of water molecules.
These bright DWI lesions represent foci of restricted
diffusion of water and are both quite sensitive and quite
specific for acute ischemia. Although reversible ischemia,
and therefore reversible diffusion restriction, without infarc-
tion is possible, it is rarely seen in clinical settings. In clinical
applications, DWI lesions are most likely infarctions with
permanent tissue loss. These silent DWI lesions typically
are small (1 to 3 mm) but can be larger. Multiple lesions per
procedure are commonly noted, with 1 to 5 commonly
described.
Carotid stenting provides an illustrative example. Early
reports describing MRI before and after carotid stenting
demonstrated small lesions with DWI sequences. These
DWI lesions were seen in patients both with and without
clinical stroke symptoms. Although the clinical stroke rate
may have been only a few percent, DWI lesions are seen in
many more. A meta-analysis performed in 2008 reviewed
studies totaling 1,363 stenting cases and a rate of new DWI
lesions of 37%. The use of a distal protection device
appeared to reduce the risk from 45% to 33% (5). A
substudy of the International Carotid Stenting Study looked
at 124 stent patients and found a rate of new DWI lesions
of 50% at 1 day with 33% of those lesions remaining
apparent on MRI at 1 month (4). Several studies of small
Estimated Annual U.S. Patients With New BrainTable 1 Estimated Annual U.S. Patients Wit
Procedures
No. of Annual
U.S. Patients
Coronary angiography 1,072,000
Percutaneous coronary intervention 596,000
Coronary artery bypass graft 242,000
Surgical aortic valve replacement 90,000
Atrial fibrillation ablation 72,000
Transaortic valve implantation 10,000
Carotid endarterectomy 93,000
Carotid artery stenting 70,000
Cerebral angiography 300,000
Endovascular aneurysm 30,000Total 2,600,000numbers of patients failed to link
DWI lesions and neurological
deficits.
Cardiac procedures, including
atrial fibrillation ablation, transaortic
valve implantation, coronary artery
bypass graft, and even coronary an-
giography procedures, have signifi-
cant rates of new DWI lesions (Table 1). These rates are much
higher than the procedural symptomatic stroke risk, and a degree
of clinical concern seems warranted.
It has been known for many years that declines in
neurological and cognitive function have followed coronary
bypass graft surgery. It has been difficult to further define
the basis of the “just not quite right” syndrome. Efforts to
avoid bypass itself have not eliminated the subsequent
cognitive and memory loss. In a 2006 review by Bendszus
and Stoll (6), DWI lesions were reported to occur in 16% to
45% of patients. The clinical significance of the DWI
lesions and subsequent neurological status in the post-
bypass patients remains unclear.
The Challenge: How to Find the Answers
The current practice of vascular procedures and interven-
tions provides important clinical benefit, with reasonable
and demonstrated safety, across a vast section of predomi-
nantly older individuals. However, available data would
suggest that new silent infarctions are much more frequent
than one would have supposed. Although there is no current
clinical proof of neurological sequelae, the data are accumu-
lating to suggest that there may be a problem. Given the
magnitude of the numbers of individuals involved, the
impact of accelerated cognitive loss and premature senes-
cence in a vulnerable at-risk population could well be
significant. The eventual management of these risks will
require multiple strategies, including improved pharmaco-
logical manipulation of clotting and platelet aggregation,
safer device design and technique, and development of
effective protection devices.
Abbreviations
and Acronyms
DWI  diffusion-weighted
imaging
MRI  magnetic resonance
imaging
onsw Brain Lesions
Incidence of New
Brain Lesions, %
No. of Annual U.S. Patients
With New Brain Lesions
11–17 118,000–182,000
11–17 66,000–101,000
16–51 39,000–123,000
38–47 34,000–42,000
8–18 6,000–13,000
68–91 7,000–9,000
4–34 4,000–32,000
15–67 11,000–47,000
11–20 33,000–60,000
10–64 3,000–19,00013–24 321,000–628,0Lesih Ne00
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The Problem With “Silent” Stroke October 23, 2012:1614–6At this point, I would argue for 2 conclusions. 1) We
must work to develop safer procedures with decreased risk
of microinfarctions using DWI lesions as a marker. 2) We
are obligated to take on the effort to study the long-term
sequelae of these DWI lesions, recognizing that this is a
monumental undertaking requiring extensive planning and
expense.
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